3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
5
Polycystic Ovary Syndrome
3
Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Venous Thromboembolism
1
Tuberous Sclerosis
1
Thrombosis
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Perioperative Inflammatory Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Margins of Excision
1
Lymphangioleiomyomatosis
1
Interventions
Carboplatin
12
Etoposide
8
Filgrastim
7
Cyclophosphamide
6
Topotecan
5
Vincristine
4
Granulocyte Colony-Stimulating Factor
4
Thiotepa
3
Melphalan
3
Cryotherapy
3
Peripheral Blood Stem Cell Transplantation
2
Mesna
2
Ifosfamide
2
Doxorubicin
2
Busulfan
2
Blood Specimen Collection
2
racotumomab
1
pegylated granulocyte colony-stimulating factor
1
etoposide phosphate
1
cixutumumab
1
becatecarin
1
alvocidib
1
Ursodeoxycholic Acid
1
Thrombopoietin
1
Thalidomide
1
Sirolimus
1
Simvastatin
1
Radiotherapy
1
Radiation
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Retinoblastoma
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled